InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-15.8%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by van den Boom Esther, Chief Financial Officer. Director active across 1 company, notably Tyra Biosciences, Inc.. In total, 4 filings have been logged. History available since 15 March 2022. The latest transaction was filed on 15 September 2022 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations4 total
1,452 shares@ US$7.658544.3% of flowCommon StockSEC:0001209191-22-050613:0
1,800 shares@ US$8.525555.7% of flowCommon StockSEC:0001209191-22-049219:0
21,254 sharesCommon StockSEC:0000899243-21-036427:0
21,254 sharesCommon StockSEC:0000899243-21-036427
4 of 4 declarations
About van den Boom Esther
Esther van den Boom is the Chief Financial Officer at Tyra Biosciences, Inc. She is responsible for the financial management of the company, including financial planning, risk management, and regulatory compliance. With deep expertise in finance, she plays a crucial role in developing financial strategies that support Tyra Biosciences' growth and innovation.
